Clear Labs Funded $18M for COVID-19 Diagnostics

Clear Labs supplies a totally- automated and smart diagnostic NGS platform robust and flexible architecture. It had actually permitted the company to develop a genomics-based essay that hasnt before existed in the medical area.

These funds plan to utilized to commercialize the companys food security platform and to leverage the underlying Next Generation Sequencing (NGS) technology in the scientific market, primarily to enhance the accessibility and quality of COVID-19 diagnostic tests.

While the lack of capability to trace infection group and transmission paths this might blaze a trail to tough resistance versus brand-new and emerging pharmaceutical interventions planned to target COVID-19.

Experts agree that the scarcity of COVID-19 screening has actually been a large factor in the spread of the infection in the United States.

This platform supports the current innovation in molecular screening by integrating DNA sequencing, bioinformatics, and robotics to secure the worldwide food supply and improve preventative food safety management systems.

Clear Labs is a US-based service provider of an automated and food safety screening technology that has been funded $18 million. The financing led by Redmile Group, Wing VC, Menlo Ventures, Tyson Ventures, and Khosla Ventures, GV, Felicis Ventures, and HBM Genomics.

Author statement:

By: K.Tagura is the leading platform for recognized financiers network worldwide. We monitor and provide updates on essential funding occasions. Angel Investors and Venture Funding can be a key growth for a startup or existing business. Whether it is an initially, second or third round funding having a strategic alliance with an Angel Investor or Venture Capital financing can move a service to the next level and provide the one-upmanship.


15 gadgets that will sell out in 2020